Moderna shares slip Wednesday amid yield pressures and recent financing
Moderna (MRNA) is lower Wednesday morning, down 3.07% to $149.54 at publication. The move comes after a trailing-month 170% surge alongside a recently closed $2.6 billion convertible notes deal as benchmark yields remain elevated.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.